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Abstract
The bfrB gene from Pseudomonas aeruginosa was cloned and expressed in E. coli. The resultant
protein (BfrB), which assembles into a 445.3 kDa complex0020from 24 identical subunits, binds 12
molecules of heme axially coordinated by two Met residues. BfrB, isolated with 5–10 iron atoms per
protein molecule, was reconstituted with ferrous ions to prepare samples with a core mineral
containing 600 ± 40 ferric ions per BfrB molecule and approximately one phosphate molecule per
iron atom. In the presence of sodium dithionite or in the presence of P. aeruginosa ferredoxin NADP
reductase (FPR) and NADPH the heme in BfrB remains oxidized and the core iron mineral is
mobilized sluggishly. In stark contrast, addition of NADPH to a solution containing BfrB, FPR and
the apo-form of P. aeruginosa bacterioferritin associated ferredoxin (apo-Bfd) results in rapid
reduction of the heme in BfrB and in the efficient mobilization of the core iron mineral. Results from
additional experimentation indicate that Bfd must bind to BfrB to promote heme mediation of
electrons from the surface to the core to support the efficient mobilization of ferrous ions from BfrB.
In this context, the thus far mysterious role of heme in bacterioferritins has been brought to the front
by reconstituting BfrB with its physiological partner, apo-Bfd. These findings are discussed in the
context of a model for the utilization of stored iron in which the significant upregulation of the bfd
gene under low-iron conditions [Ochsner, U.A., Wilderman, P.J., Vasil, A.I., and Vasil, M.L.
(2002) Mol. Microbiol. 45, 1277–1287] ensures sufficient concentrations of apo-Bfd to bind BfrB
and unlock the iron stored in its core. Although these findings are in contrast to previous speculations
suggesting redox mediation of electron transfer by holo-Bfd, the ability of apo-Bfd to promote iron
mobilization is an economical strategy used by the cell because it obviates the need to further deplete
cellular iron levels to assemble iron sulfur clusters in Bfd before the iron stored in BfrB can be
mobilized and utilized.
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Iron is the fourth most abundant element in Earth’s crust, after oxygen silicon and aluminum
and the second most abundant metal. With a few exceptions, iron is a required nutrient because
the metal ion is incorporated as cofactor in proteins and enzymes involved in a wide range of
biological processes (1). Under biological conditions iron is present mainly in two oxidation
states, the soluble Fe2+ which can react with O2 to form reactive oxygen species and the highly
insoluble Fe3+ ion. These chemical properties present living organisms with enormous
challenges for the acquisition and homeostasis of this nutrient. One mechanism whereby iron
toxicity can be ameliorated or controlled is by storage of excess iron in ferritin and ferritin-
like molecules. These molecules, found in prokaryotes and eukaryotes (2), likely evolved to
combat the insolubility of Fe3+ and the toxicity of Fe2+ in aerobic environments, because they
function by oxidizing Fe2+ using O2 and H2O2 as electron acceptors and by internalizing and
compartmentalizing the resultant Fe3+ in the form of a mineral. Consequently, ferritin and
ferritin-like molecules may also contribute to managing oxidative stress triggered by increased
concentrations of “free” cellular Fe2+ (3). Intracellular reserves of iron in bacteria are placed
in three types of ferritin-like molecules; the classic ferritins, which are also present in
eukaryotes, the bacterioferritins, which are present only in eubacteria, and the Dps proteins,
which are present only in prokaryotes (1). Ferritins are composed of 24 subunits that assemble
into a spherical protein shell surrounding a central cavity where the iron mineral is stored.
Bacterioferritins are also assembled from 24 subunits into a similar structure that harbors 12
heme molecules, and Dps proteins which assemble from 12 subunits to form a central cavity
smaller than those formed by ferritins and bacterioferritins.
Early studies with bacterioferritin from P. aeruginosa suggested that the protein is composed
of two subunits, termed α- and β-. Although the relative proportions of the two subunits varied
widely from preparation to preparation, the α-subunit was the most abundant (4). More recent
investigations have established that there are two genes coding for bacterioferritin molecules
in P. aeruginosa, termed bfrA and bfrB (5). In Figure 1 the amino acid sequences of BfrA and
BfrB from P. aeruginosa are compared with the sequences of structurally characterized
bacterioferritins from E. coli (6), Azotobacter vinelandii (7) and Mycobacterium smegmatis
(8). As indicated above, the structure of bacterioferritin is an assembly of 24 subunits that forms
a nearly spherical, hollow molecule that binds 12 heme molecules, where each heme is
coordinated by two Met residues (Met52) from a pair of subunits related to one another by
two-fold symmetry. It is interesting that Met52 is absent from the sequence of BfrA, suggesting
that the latter may not bind heme. In comparison, residues that act as ligands to the di-iron
ferroxidase center are conserved in all the amino acid sequences shown in Figure 1, including
that of BfrA. Thus, the amino acid sequence of BfrA, which indicates a full ferroxidase center
but no heme-binding Met52 suggests that BfrA is a misnomer, as the bfrA gene likely codes
for a bacterial ferritin and not a heme binding bacterioferritin. The bfrA gene is adjacent to the
KatA gene, which codes for a catalase active in all growth phases, and is thought to be involved
in imparting resistance to hydrogen peroxide. A bfrA mutant of P. aeruginosa was found to
express only ~ 50% of the catalase activity observed in wild type cells due to a decrease in the
synthesis of KatA. This observation, and the nearly complete restoration of catalase activity
brought about by complementation with a plasmid expressing the bfrA gene, led to the
suggestion that iron stored in BfrA is incorporated into protoporphyrin IX to make the heme
cofactor of KatA (5).
The bfrB gene in P. aeruginosa and in several other bacteria is adjacent to a bfd gene, which
codes for a small protein known as Bfd (bacterioferritin associated ferredoxin). Genes coding
for Bfd in E. coli (9,10) and in P. aeruginosa (11) have been cloned and their products shown
to bind a [2Fe-2S] cluster. Although the function of Bfd is unknown, the ability of the
recombinant protein to incorporate an iron sulfur cluster has been used to suggest that this small
protein serves either as a scaffold for [2Fe-2S] cluster assembly and/or it aids in the uptake or
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release of iron from BfrB by mediating electron transport. An investigation of the global
transcriptional response of iron-starved cultures of P. aeruginosa exposed to iron showed that
mRNA levels of bfrB increased significantly (24-fold) when iron was made available, whereas
bfrA mRNA levels remained unchanged (12). These observations are in agreement with
previous findings indicating that in P. aeruginosa BfrA is expressed constitutively (13),
whereas BfrB is expressed under high-iron conditions (13,14). In comparison, the bfd gene is
upregulated ~ 200-fold under low iron conditions (15). This differential regulation of the
contiguous bfrB and bfd genes in response to cellular iron levels prompted us to hypothesize
that Bfd synthesized under low-iron conditions functions to aid in the mobilization of iron
stored in existing BfrB molecules.
Ferritin and bacterioferritin function by capturing excess cellular iron and storing it in the form
of a ferric mineral. When cellular iron concentrations become limiting to metabolism, stored
iron can be mobilized from ferritin or bacterioferritin to meet metabolic demands that involve
incorporation of the nutrient in ubiquitous cofactors such as heme, non-heme iron centers and
iron sulfur clusters. A significant volume of work has been carried out to understand the process
of iron mineralization by ferritin and bacterioferritin, which starts with the binding of two
ferrous ions to the highly conserved residues that act as ligands of the di-iron ferroxidase center
(16–19). The two Fe2+ ions are oxidized by O2 and the resultant Fe3+ ions migrate to the cavity,
where a ferrihydrite mineral is formed in the ferritins and a ferric phosphate mineral is formed
in the bacterioferritins (20). In comparison, little detail is known about the process whereby
mineralized iron is mobilized from the bacterioferritin cavity. Investigations conducted with
ferritins from eukaryotes suggested that reduction of Fe3+ to Fe2+ by electrons shuttled from
NADPH by way of a flavin-nucleotide is the more plausible mechanism for the mobilization
of the iron stored in ferritin (21). Results from more recent work, also carried out with ferritins
from eukaryotes, suggest that pores in the structure of ferritin reversibly unfold in the presence
of millimolar concentrations of urea and largely increase the rate of iron release in vitro (22–
24). These observations have led to the hypothesis that a yet unknown specific flavoprotein
binds near the pores of ferritin, altering the dynamics of pore opening and closing and
enhancing the rate of Fe3+ reduction and Fe2+ mobilization (25). In contrast, the issue of iron
mobilization from bacterioferritins remains nearly completely enigmatic. Although X-ray
crystal structures of bacterioferritins from different bacterial sources corroborated that these
molecules bind 12 heme groups (8,26–28), it is believed that the heme molecules do not play
a role in iron mineralization, and their participation in iron mobilization from the core by
facilitating Fe3+ reduction has been speculated but not demonstrated (29). In this report we
present evidence that mobilization of iron stored in BfrB requires the presence of Bfd.
Unexpectedly, the function of Bfd in iron mobilization is not the mediation of electrons from
NADPH to the bacterioferritin; rather, apo-Bfd (devoid of its iron sulfur cluster) promotes the
rapid mobilization of stored iron by binding to BfrB. Formation of a complex also affects the
heme cofactor in BfrB, which is seen to mediate electrons from the surface to the core only if
Bfd is bound to the bacterioferritin.
EXPERIMENTAL PROCEDURES
Cloning of Pseudomonas aeruginosa BfrB
The gene encoding for P. aeruginosa BfrB (PA3531) was synthesized, subcloned into a pET
11a vector and sequenced (GeneScript Corp., Pisctaway, NJ). The gene was engineered with
silent mutations introducing codons favored by E. coli (30) and with Nde I and BamH I
restriction enzyme sites at the 5’ and 3’ ends, respectively for subcloning into the pET 11a
vector (Figure S1). The pET 11A vector harboring the bfrB gene was then transformed into
E.coli Arctic express RIL competent cells (Stratagene).
Weeratunga et al. Page 3













Expression and purification of P. aeruginosa BfrB
A single colony of E. coli Arctic express RIL cells harboring the recombinant pET11-a/bfrB
construct was cultured overnight at 37 °C in 50 mL of LB medium containing 100 µg/mL
ampicilin and 20 µg/mL gentamicin. The cells were subsequently subcultured in 1 L of fresh
LB containing no antibiotics and grown for 3 h at 37 °C. Cells were then transferred to a shaker
incubator pre-equilibrated at 10 °C and incubated for 30 min before protein expression was
induced by addition of isopropyl 1-thiol-D-galactopyranose (IPTG) to a final concentration of
1 mM. Cells were cultured for additional 20 h at 10 °C before they were harvested by
centrifugation (4500 rpm for 10 min) and stored at −20 °C. The cell paste was resuspended in
50 mM Tris-HCl, pH 7.6 (2 mL/g cell paste) and PMSF (0.5 mM), DTT (5 mM), protease
inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and DNAse (Sigma-Aldrich, St. Louis, MO)
were added before the cells were lysed by sonication on ice. Cell debris were pelleted by
centrifugation at 4 °C and 23,500 rpm and the resultant supernatant was loaded onto a Q-
Sepharose Fast Flow column (12 cm × 2.5 cm i.d.) equilibrated with 50 mM Tris-HCl (pH
7.6). The column was washed with three column volumes of 50 mM Tris-HCl (pH 7.6) before
the protein was eluted using the same buffer and a linear gradient (0 mM – 600 mM) of NaCl.
Fractions containing BfrB were pooled and reconstituted with heme by titrating with a solution
of hemin (2 mg/mL in DMSO) until the absorbance of the Soret band (418 nm) no longer
changed. The resultant protein solution was dialyzed against 4 L of 50 mM Tris-HCl (pH 7.6)
for 12 h at 4 °C with at least two buffer changes. The resultant solution was then applied to a
hydroxyapatite Bio-Gel column (10 cm × 2.5 cm i.d.) and washed with approximately 5 column
volumes of 50 mM Tris-HCl (pH 7.6). BfrB was eluted with a linear gradient of potassium
phosphate (50 mM–800 mM, pH 7.6). Fractions containing BfrB (red) were pooled and
dialyzed overnight against 4 L of 50 mM Tris-HCl (pH 7.6) at 4 °C, with at least two buffer
changes; the resultant solution was loaded to a second Q-Sepharose Fast Flow column (12 cm
× 2.5 cm i.d.) and eluted as described above for the first ion exchange column. Fractions
containing BfrB were loaded onto a second hydroxyapatite Bio-Gel column (10 cm × 2.5 cm
i.d.) and the protein eluted using conditions identical to those described above for the first
hydoxyapatite column. Fractions with absorbance ratio A280/A418 < 0.7 were pooled and
dialyzed against 100 mM potassium phosphate (pH 7.6) and determined to be pure by SDS-
PAGE.
Determination of molecular weight
The molecular weight of BfrB and that of the BfrB:Bfd complex were estimated with the aid
of a high resolution size exclusion column (Superdex 200 16/60 Prep, GE Healthcare)
equilibrated with 100 mM potassium phosphate (pH 7.6) and 1 mM tris (2-carboxyethyl)-
phosphine hydrochloride (TCEP). The column was calibrated with a set of molecular weight
standards (GE Healthcare) that included ferritin (440,000 Da), aldolase (158,000 Da),
conalbumin (75,000 Da) and ovalbumin (43,000 Da).
Mineralization of iron in the BfrB cavity
As isolated, BfrB contains only a small amount of iron in its core (~ 5 – 10 iron atoms per
molecule). Stocks of protein harboring ~ 600 iron atoms per molecule were prepared as follows:
A solution of ferrous ammonium sulfate was prepared inside an anaerobic chamber (Coy Labs,
Grass Lake, MI), placed in a container capped with a rubber septum and removed from the
anaerobic chamber. Concentrated HCl was added to the ferrous ammonium sulfate solution
(50 µL/100 mL) through the septum with the aid of a Hamilton micro syringe and a needle.
The resultant solution was added to a stirred solution of 0.003 mM BfrB and 1.0 mM TCEP
in 100 mM potassium phosphate buffer pH 7.6, in aliquots delivering 10% of the total iron
necessary to load each BfrB molecule with 600 iron atoms. Fifteen minutes after the addition
of an aliquot the resultant solution was transferred to an Eppendorf tube and centrifuged for
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10 min at 4000 rpm. The supernatant was carefully transferred back into the reaction beaker
before the following aliquot was added. The mineralization process was monitored
spectrophotometrically using the 280 absorbance corresponding to the iron mineral (31) with
the aid of a USB 2000 spectrophotometer (Ocean Optics, Dunedin, FL). The content of iron
in the core was determined using previously reported methodology (32). In short, one mL of
concentrated HCl was added to 1 mL of BfrB (0.003 mM) and the mixture incubated for 15
min, followed by addition of 1 mL of ascorbic acid (25 g/L) and 5 mL of saturated aqueous
sodium acetate. A purple color developed upon the addition of 1 mL of ferrozine (5 g/L) and
after 20 min the concentration was determined from the electronic absorption spectrum using
the absorbance at 562 nm (ε562 = 27.9 mM−1 cm−1).
Mobilization of core iron from BfrB
Experiments to investigate the mobilization of core iron from BrfB were carried out in an
anaerobic chamber. Reactions were conducted in a 1.0 cm path-length cuvette equipped with
a magnetic stirring bar and monitored by electronic absorption spectroscopy using an Ocean
Optics (Dunedin, FL) 2000 spectrophotometer. A few µL from stock solutions were added to
a cuvette containing 3 mM 2,2, bipyrydil (bipy) in 1.5 mL of 20 mM potassium phosphate
buffer (pH 7.6), to make a solution 15 µM in Bfd, 15 µM in FPR and 0.375 µM in BfrB. The
reaction was initiated by addition of NADPH to a final concentration of 1.5 mM and the
progress monitored by following the time-dependent changes in intensity of the band at 523
nm that is formed when bipy binds Fe2+ to form the [Fe(bipy)3]2+ complex. Experiments with
apo-Bfd were conducted with a simple modification of the above procedure: Apo-Bfd was
prepared in situ from holo-Bfd. To this end, holo-Bfd (15 µM final concentration) was added
to a stirred cuvette containing 3 mM bipy in 20 mM potassium phosphate buffer (pH 7.6).
Sodium dithionite (5 mM) was added to stoichiometrically reduce the Fe3+ in holo Bfd to
Fe2+. Capturing of the ferrous ion by bipy was monitored by the time-dependent increase in
the 523 nm absorbance, which was followed until it reached a plateau with intensity
corresponding to the theoretical value calculated from the amount of holo Bfd placed in the
cuvette. At this point, the solution containing apo-Bfd was reconstituted with FPR and BfrB
(final concentrations of 15 µM and 0.375 µM, respectively) and the iron mobilization reaction
initiated by the addition of NADPH to a final concentration of 1.5 mM.
RESULTS
Expression and purification of P. aeruginosa FPR, wild type Bfd and Cys43Ser Bfd
Ferredoxin NADP reductase from Pseudomonas aeruginosa (FPR) was expressed and purified
as described previously (11,33). Expression and purification of P. aeruginosa Bfd was carried
out according to a previously described procedure (11) with the following modifications: In
the previously described procedure Bfd was expressed in E. coli BL21(DE3) cells at 30 °C,
which produced apoprotein encapsulated in inclusion bodies. Purification required
denaturation with urea to solubilize the protein, in vitro reconstitution of the [2Fe-2S] cluster
and subsequent chromatographic purification. In the present investigation the preparation of
Bfd was facilitated by expressing it in E. coli Arctic Express RIL cells which produced soluble
Bfd with an intact iron sulfur cluster. Although the preparation of P. aeruginosa Bfd was
facilitated by use of the Arctic Express cells, the relatively low yield of protein (1–2 mg/L)
was similar to that obtained previously; poor yields have also been reported for the expression
of recombinant E. coli Bfd (10). The iron sulfur cluster in wild type Bfd is fragile and it tends
to be lost or “damaged” during purification and sometimes during cryogenic storage. Inspection
of the amino acid sequence of P. aeruginosa Bfd (Figure 2) shows that the 73-residue long
protein contains 7 Cys, four of which are conserved; the latter are highlighted in red in the
sequences corresponding to Bfd proteins from different organisms. Each of the three non-
conserved Cys residues in P. aeruginosa Bfd was mutated to Ser in an attempt to increase the
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yield of expression and to stabilize the iron sulfur cluster of the recombinant protein. Mutation
of Cys 22 or Cys 23 appears to have a negative impact on the fold of the protein because
expression of these mutants did not yield detectable amounts of polypeptide, as judged by
polyacrylamide gel electrophoresis. In contrast, the C43S mutant of Bfd can be expressed in
yields (~ 4 mg/mL) that are at least two fold higher than those obtained with wild type Bfd. In
addition, the [2Fe-2S] cluster in the C43S mutant, which is more resistant to purification,
manipulation and to storage, exhibits an electronic absorption spectrum identical to that
exhibited by wild type Bfd (Figure S2).
Overexpression, Purification and Characterization of BfrB
The BfrB protein expressed in E.coli Arctic express RIL cells is soluble and can be purified to
homogeneity, as judged by the presence of a single band in the SDS-PAGE gel shown in Figure
3-A. The band corresponds to an approximate MW of 18,000 Da., which is in agreement with
the molecular weight calculated from the amino acid sequence of a BfrB subunit (18,553 Da).
The molecular weight of BfrB, estimated from its average elution volume (Ve = 58.9 ± 0.05
mL) from a Superdex 200 column calibrated as described in Experimental Methods is 447 ±
1 kDa (see Figure 8-A). This estimated MW indicates that it is composed of 24 subunits of
MW 18.6 kDa, a value that is in good agreement with the 18.553 kDa per subunit value
calculated from the amino acid sequence. The electronic absorption spectrum of pure BfrB
with its heme-iron in the Fe3+ oxidation state is reminiscent of spectra obtained from other
bacterioferritins, with a Soret band maxiumum at 418 nm, and α and β bands at 567 and 527
nm, respectively (solid trace in Figure 3-B). In addition, the spectrum displays the characteristic
weak band at 740 nm (inset) indicative of heme coordinated by two axial methionine ligands
(34). The spectrum of BfrB with its heme iron in the Fe2+ oxidation state, obtained upon
addition of sodium dithionite (segmented trace in Figure 3-B), shows the Soret band at 425
nm, the α and β bands at 567 and 527 nm, respectively and no absorption near 740 nm, as
expected. It is important to note that the spectrum of reduced heme was obtained with a sample
of BfrB with a core devoid of iron mineral (~ 10 Fe atoms/BfrB). When the core is reconstituted
with iron, on the other hand, the heme cannot be reduced, even if a large excess of dithionite
is added under strict anaerobic conditions.
In the process of establishing the purification protocol it was observed that BfrB-containing
fractions eluting from the first ion exchange column (see Experimental) exhibited a faint red
color, despite the fact that the protein concentration was high, as judged by the relative intensity
of the subunit band in SDS-PAGE gels. This observation, which suggested the possibility that
BfrB does not incorporate a full complement of heme when expressed in E. coli, was followed
by reconstituting protein eluting from the first ion exchange column with heme. In the family
of electronic absorption spectra obtained during the reconstitution process (Figure 3-C) the
dotted trace, obtained before heme was added, shows an A280/A417 ratio > 10. Reconstitution
with heme causes a large increase in the intensity of the Soret band, and a final A280/A417 ratio
< 1 (solid trace). The large increase in the intensity of the Soret band upon reconstituting BfrB
with heme confirms that the protein as isolated from the E. coli expressing strain has a low
content of heme. Analysis of heme content in protein purified to homogeneity after in vitro
reconstitution with the cofactor showed that BfrB binds 12 heme groups. Hence, BfrB is similar
to other structurally characterized bacterioferritins in that it consists of 24 subunits that
incorporate 12 heme molecules axially coordinated by two Met ligands. Analysis of the iron
content in the core of BfrB as isolated from E. coli revealed the presence of 5–10 atoms of iron
per protein molecule.
In attempts to circumvent the low iron and low heme content in as-isolated recombinant BfrB
the expression medium was supplemented with (a) Fe(SO4)2 (4 mg/L) and δ-aminolevulinic
acid (ALA) (17 mg/L) or (b) Fe(SO4)2 (4 mg/L) and hemin (5 mg/L). ALA was utilized because
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it has been shown that culture medium supplemented with the latter increases the yield of heme-
bound recombinant proteins (35,36). The content of heme and iron in recombinant BfrB
expressed in E. coli cultured in LB medium supplemented with iron and ALA (or hemin)
remained similar to those obtained from expressing BfrB in non-supplemented LB medium.
The low content of iron in the core and the limited incorporation of heme in as isolated
recombinant BfrB may be a consequence of overexpressing (40 mg/L) a protein that binds
several heme molecules and is avid for iron, which places strain on the iron uptake and iron
homeostasis processes of the host E. coli strain. Alternatively, it is possible that in the P.
aeruginosa cell chaperones deliver and facilitate the binding of heme to BfrB. It is also
interesting that heme appears to play an important role in the long-term stability of BfrB
because attempts to purify it without reconstituting it with heme did not produce properly
assembled dodecameric protein: BfrB devoid of heme was purified to homogeneity as judged
by the presence of a single band, corresponding to a BfrB subunit (~ 18,000 Da), in an SDS
PAGE gel. Determination of molecular weight in a Superdex 200 column, however, revealed
the absence of a peak with elution volume corresponding to a dodecamer (MW 447 kDa).
Instead, three main peaks were observed with Ve corresponding to molecular weights of
approximately 30 kDa, 92 kDa and 254 kDa.
Preparation of iron loaded BfrB
Protein containing ~ 600 iron atoms per BfrB molecule was prepared by titrating an anaerobic
solution of Fe2+ into a solution of BfrB in air. Ferrous ions added with each aliquot are oxidized
by two competing reactions: In the dominant process, Fe2+ is oxidized by BfrB using dissolved
O2 as an electron acceptor and then incorporated into the Fe3+ mineral in the core of the
bacterioferritin. In the competing process Fe2+ is oxidized by dissolved O2 without the
participation of BfrB; the resultant Fe3+ is rapidly hydrolyzed to an insoluble colloidal hydrous
oxide. Formation of the latter can result in significant loss of protein, presumably
electrostatically associated to the colloid. To minimize the loss of protein during the preparation
of iron-loaded BfrB, aliquots of Fe2+, each containing ~ 10% of the total iron were added
approximately 15 min apart to allow for uptake, oxidation and mineralization, before the small
amounts of colloidal iron oxide formed with each addition of Fe2+ were separated by
centrifugation. The dotted trace in Figure 4, obtained before the addition of Fe2+ to a solution
of BfrB harboring 10 iron atoms per protein molecule, displays A280/A418 ratio of 0.69.
Incorporation of iron into the cavity induces a gradual increase in the intensity of the absorption
ca. 280 nm because mineralized iron gives rise to absorption similar to band-edge bands
displayed by polycrystalline semiconductors (31). The family of spectra in Figure 4 also shows
that as the intensity of the band near 280 nm increases, the intensity of the Soret band remains
almost unchanged; the small decrease in Soret band intensity is due to small losses of protein,
presumably precipitated by small amounts of colloidal hydrous oxide formed with each
addition of Fe2+. That the small amounts of colloid formed after each addition of Fe2+ are
removed efficiently by the centrifugation step is evident in the preservation of baseline in the
family of spectra; in the presence of colloids the baseline would drift toward higher absorbance
values. This approach allowed for a relatively high recovery of protein, typically ~85%, with
a consistent content of iron, 600 ± 40 iron atoms per protein molecule and phosphate to iron
ratio of ~ 1.3. This relatively high phosphate content is typical of bacterioferritins isolated from
native sources (19,20,37–39).
Interactions with apo-Bfd unlock the iron stored in BfrB
All experiments aimed at probing the mobilization of core iron from BfrB were carried out
under anaerobic conditions. Iron mobilization was initiated by addition of NADPH (1.5 mM
final concentration) to a cuvette containing a solution of the appropriate protein mixture and
bipy (3 mM). The release of core iron was monitored by following the time-dependent
formation of the ferrous bipyridine complex, [Fe(bipy)3]2+, which exhibits absorption
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maximum at 523 nm. The black circles in Figure 5-A correspond to the time dependent changes
in absorbance at 523 nm following addition of NADPH to a solution containing BfrB (0.375
µM) and FPR (15 µM). The open circles correspond to the time dependent growth of the 523
nm band upon addition of NADPH to a solution containing wild type holo-Bfd (15 µM) in
addition to BfrB (0.375 µM) and FPR (15 µM). It is evident that the presence of Bfd causes a
significant acceleration in the rate of iron release, indicating that this small protein plays an
important role in the mobilization of core iron from BfrB. It is also noteworthy that in the
experiments conducted in the absence of Bfd (black circles) the Soret band remains at 417 nm
(oxidized heme) throughout the experiment, which is in contrast with the rapid shift of the
Soret band toward 425 nm that is observed when wild type holo-Bfd is present.
From the above observations it is tempting to assume that the [2Fe-2S] cluster of holo-Bfd
catalyzes iron mobilization by shuttling electrons from FPR to BfrB. Results from an
experiment in which wild type Bfd devoid of its [2Fe-2S] cluster (apo-Bfd) was used in lieu
of holo-Bfd, however, indicate that Bfd does not participate in core iron mobilization by
mediating electron transfer to BfrB. In these experiments wild type apo-Bfd was prepared in
situ by incubating the holo protein with dithionite and bipy in a cuvette with constant stirring,
in order to capture the iron in the [2Fe-2S] cluster as the [Fe(bipy)3]2+ complex. This process,
although relatively slow (~ 170 min), is obvious in the appearance and growth of the
characteristic 523 nm band (black circles in Figure 5-B). Evidence for the quantitative
formation of apo-Bfd was obtained from the yield of [Fe(bipy)3]2+ calculated from the
maximum intensity of the 523 nm band when it no longer changed with time, which is in
excellent agreement with the amount of [Fe(bipy)3]2+ predicted to form if all the iron in the
[2Fe-2S] cluster is captured by bipy. BfrB and FPR were subsequently added to the solution
containing apo-Bfd, and the iron mobilization reaction started by the addition of NADPH
(marked by an arrow). The fast growth in the intensity of the 523 absorbance that ensues upon
addition of NADPH is also accompanied by rapid reduction of heme. To facilitate comparison,
the time-dependent changes in the intensity of the 523 absorbance promoted by the presence
of wild type apo-Bfd are shown with triangles in Figure 5-A, where it can be seen that the rate
of iron release observed in the presence of apo-Bfd is slightly faster than that observed in the
presence of holo-Bfd. These findings demonstrate that the [2Fe-2S] cluster of holo-Bfd is not
necessary for the rapid mobilization of core iron and that Bfd does not function by shuttling
electrons to BfrB. Rather, the effect exerted by Bfd on core iron mobilization appears to be
brought about by binding to BfrB, presumably promoting conformational changes in the latter
that enable the release of stored iron mineral.
As indicated above, the yield of recombinant wild type Bfd is significantly lower than that of
the C43S mutant. In addition, the [2Fe-2S] cluster in the wild type protein has a tendency to
degrade during protein purification and occasionally during protein storage. Cluster
degradation leads to oligomerization of Bfd., presumably via formation of disulfide linkages.
In an attempt to circumvent the limitations imposed by the low yields and fragility of wild type
Bfd, the non-conserved Cys43 was mutated to a Ser. The mutant can be isolated pure in
reasonable yield (4 mg per liter of culture) and is relatively more stable to manipulation and
storage. The electronic absorption spectrum is identical to that of wild type Bfd (Figure S1),
indicating that the mutation did not impair the fold of the protein or its ability to bind a [2Fe-2S]
cluster. Apo-C43S Bfd was prepared in a cuvette in a manner similar that described above for
the wild type protein. When the iron in the [2Fe-2S] cluster had been quantitatively captured
as the [Fe(bipy)3]2+ complex, BfrB, FPR and NADPH were added to the cuvette and the iron
mobilization reaction was followed by monitoring the growth in the intensity of the 523 nm
absorbance. The time-dependent release of core iron promoted by the apo-form of the C43S
mutant of Bfd (open circles in Figure 5-B) is nearly identical to the time-dependent release of
iron promoted by apo-wild type protein. Consequently, subsequent studies involving Bfd were
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conducted with the C43S mutant to capitalize from its higher expression yields and enhanced
stability. For simplicity, hereafter the C43S mutant of Bfd will be referred to as Bfd.
Results obtained from probing the effect of apo-Bfd concentration on the mobilization of core
iron are summarized in Figure 6-A. In these experiments the concentrations of BfrB (0.375
µM) and FPR (15 µM) were maintained constant, while the concentration of Bfd was changed
to explore conditions encompassing Bfd/BfrB ratios of 40:1 (green), 30:1 (red), 20:1 (purple),
15:1 (cyan), 10:1 (blue), 5:1 (orange) and 0:1 (black) . Lowering the Bfd/BfrB ratio from 40
to 5 causes a periodic slowing of iron release, followed by a pronounced change when the ratio
is changed from five to zero. The accompanying plots in Figure 6-B, color coded as in Figure
6-A, show the time-dependent shift of the Soret band from 417 nm (ferric heme) to 425 nm
(ferrous heme). It is apparent that when the Bfd/BfrB mole ratios are >5 the heme is reduced
in an initial “fast phase” followed by a “slower phase” that continues until the Soret band has
shifted to 425 nm (100 % reduction). A progressive slowing of each of the two phases is
observed as the Bfd/FPR ratio is decreased from 40 to 5, while in stark contrast, in the absence
of Bfd the Soret band remains at 417 throughout the duration of the experiment. Closer
examination of the first 10 min of the iron mobilization reaction (Figure 6-C) and of the progress
of heme reduction (Figure 6-D) reveals a lag phase lasting approximately 1–3 min (Figure 6-
C) when the Bfd/BfrB ratio is 20 or lower. The fact that the lag in heme reduction tracks with
the lag in iron mobilization suggests that electrons leaving the reductase (FPR) are channeled
into the mineral core via the heme. Additional evidence supporting this notion is presented
later in this report. In order to facilitate a more quantitative comparison of the rates of iron
mobilization at varying concentrations of apo-Bfd, a pseudo rate was estimated by fitting the
curves to an exponential function; data points corresponding to the lag phase observed when
Bfd/BfrB < 20 were not included in the fit. The results, summarized in Table 1 and Figure 7,
show a clear Bfd-dependent acceleration of core iron mobilization from BfrB.
Bfd binds to BfrB
The observations described above strongly suggest that Bfd binds to BfrB. Additional evidence
supporting the formation of a complex was obtained with the aid of size exclusion
chromatography: The average volume of elution (Ve) corresponding to the peak obtained upon
loading a Superdex 200 column with a 1.0 mL solution containing 0.0036 µmol of BfrB is 58.9
± 0.05 mL (open circle in Figure 8-A). This value, which is nearly identical that obtained upon
loading the column with the horse spleen ferritin standard, corresponds to an estimated
molecular weight of 447 ± 1 kDa. In comparison, the avergae Ve corresponding to the peak
obtained upon loading the column with 1.0 mL of a mixture containing 0.0036 µmol of BfrB
and 0.0864 µmol of Bfd is 57.0 ± 0.6 mL and corresponds to an estimated molecular weight
of 538 ± 30 kDa (open triangle in Figure 8-A). Excess Bfd elutes from the column significantly
later (Ve = 96.3 ± 0.3 mL). The 91 kDa difference in the molecular weights estimated from the
average elution volumes of pure BfrB and a BfrB-Bfd mixture corresponds to approximately
12 Bfd molecules, each with a molecular weight of 7.82 kDa. This observation suggests that
12 molecules of Bfd can bind a molecule of BfrB, which makes it tempting to speculate that
one molecule of Bfd binds per subunit dimer of BfrB. In order to obtain additional evidence
corroborating that Bfd elutes from the column together with BfrB, solutions corresponding to
each peak in the chromatogram were analyzed by SDS page. The results presented in Figure
8-B show that the solution corresponding to the peak with elution volume 57.0 ± 0.6 mL (lane
2) is indeed a mixture of BfrB and Bfd, whereas the solution corresponding to the peak with
elution volume 96.3 ± 0.3 mL (lane 1) contains only Bfd.
Binding of Bfd to BfrB enables heme mediation of electron transfer to the core
The idea that electron transfer from the reductase to the core mineral in BfrB is mediated by
heme was further tested in an experiment where a limiting amount of NADPH, 15% of the
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total reducing equivalents needed to mobilize all the core iron, was added to a solution
containing apo-Bfd, FPR and BfrB in molar proportion 40:40:1. These conditions were chosen
because when the proportion of Bfd to BfrB is larger than 20, no lag phase is observed for iron
mobilization or heme reduction (see Figure 6). The results, summarized in Figure 9, show rapid
release of iron (open circles, left axis) with the addition of each aliquot of NADPH. The amount
of Fe2+ released (0.043 ± 0.02 µmol) with each aliquot of NADPH is consistent with the number
of electron equivalents (0.044 µmol) delivered, indicating quantitative utilization of NADPH.
The plot of Figure 9 also shows that following each addition of NADPH the position of the
Soret band shifts rapidly from 417 nm toward 425 nm and then back to its original position
(closed circles, right axis), indicating a transient buildup of reduced heme. This transient
buildup, which is indicative of a balance between reduction and subsequent oxidation of heme,
strongly suggests that heme is reduced by electrons from the reductase faster than it is
reoxidized by transferring those electrons to the core mineral. This idea finds additional support
in the fact that the transient concentration of reduced heme increases with each addition of
NADPH because as the size of the core mineral becomes progressively smaller, the electron
demand decreases. Hence, if the electron flux from the surface to the heme is similar after each
addition of NADPH but the electron flux from heme to the core decreases as the mineral shrinks,
the transient concentration of reduced heme should be larger with each addition of NADPH,
a prediction that is mirrored in the experimental observations summarized in Figure 9.
DISCUSSION
The mobilization of ferritin iron in the cytosol of hepatic cells was shown to be promoted by
electrons from NADH or NADPH which are shuttled to the ferritin via flavin- or xanthine-
containing oxidoreductases (21). Consequently, work aimed at studying iron mobilization from
mammalian ferritins utilizes FADH2 as an electron donor. In early work FADH2 was generated
by NADH-flavin oxidoreductase (40) while in more recent studies FADH2 is generated by the
beam of a spectrophotometer in the presence of NADH (41). In comparison, investigations of
core iron mobilization from bacteriferritin have employed small molecule reductants such as
dithionite or methyl viologen (42) because previous to this report virtually nothing was known
about the process of electron delivery to the core iron of bacterioferritins or about the nature
of the molecules that participate in the mobilization of stored iron. The present investigations,
which were conducted with the aim of bridging these gaps, build from information obtained
by probing the global genetic response of P. aeruginosa to iron levels (15). Amongst the genes
reported to be positively regulated by low iron conditions, we previously noted those coding
for Bfd and FPR because of their probable function in electron transfer (11). Biochemical and
structural characterization of the Bfd and FPR proteins from P. aeruginosa allowed us to
establish that FPR supports the catalytic activity of heme oxygenase by transferring the 7
electrons needed by this enzyme to degrade heme and release its iron (11). Hence, the NADPH
dependent FPR was used in this work because it is the product of one of the two positively
regulated genes coding for an electron transfer protein under iron starvation conditions and
because it utilizes FADH2 as cofactor, like the flavin oxidoreductases implicated in delivering
electrons to mammalian ferritin. The other positively regulated gene coding for a putative
electron transfer protein is termed bacterioferritin associated ferredoxin (Bfd). The Bfd proteins
from E. coli and from P. aeruginosa have been characterized and shown to bind a [2Fe-2S]
cluster (9–11), observations that led to the hypothesis that Bfd may function in iron
mobilization by mediating electron transfer to the iron core of BfrB (9,10) or alternatively,
function in iron mineralization by mediating electron transfer from the core to an external
oxidant (10). In this context, it is significant that conditions of low-iron stress cause the bfrB
gene to be down regulated (12) and the bfd gene to be strongly up regulated (15), because it
suggests that Bfd is synthesized to aid in the mobilization of iron stored in BfrB, with the
purpose of sustaining metabolic activity while additional mechanisms, also activated in
response to iron starvation, procure the nutrient from extracellular sources. In the context of
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this hypothesis, holo Bfd would be expected to mediate electron transfer from NAD(P)H to
the core iron in BfrB. Results from experiments aimed at testing the hypothesis showed that
holo-Bfd promotes the efficient mobilization of core iron from BfrB, which would seem to
support the notion that Bfd participates in iron mobilization by shuttling electrons to BfrB.
Results obtained from additional experimentation aimed at testing the hypothesis, however,
did not support this idea. Instead, these experiments conclusively demonstrated that apo-Bfd
is effective in promoting the release of Fe2+ from BfrB, therefore demonstrating that assembly
of a [2Fe-2S] cluster is not necessary for Bfd to exert its influence in iron mobilization. The
collective evidence indicates that protein-protein interactions between apo-Bfd and BfrB
promote the effective mobilization of iron stored in bacterioferritin.
Although these findings may appear at first to be surprising in light of previous expectations
implicating the [2Fe-2S] cluster of Bfd, additional consideration makes it evident that
bypassing the assembly of an iron-containing cofactor to mobilize and utilize iron stored in
BfrB is an economical strategy when cellular levels are low. Hence, when these new
observations are placed in the context of the known genetic response of P. aeruginosa to high-
and low-iron conditions, a model for the efficient utilization of stored iron emerges: Down
regulation of the bfrB gene clearly indicates that synthesis of additional BfrB protein is not
necessary during periods of iron starvation. Iron stored in BfrB, however, is likely utilized for
cell survival while additional mechanisms of iron acquisition are deployed to procure the
nutrient from extracellular sources. Efficient release of iron from BfrB requires formation of
a BfrB:Bfd complex with probable stoichiometry 1:12, which is in agreement with the strong
positive regulation of the bfd gene by low-iron conditions. An electron transfer role for Bfd in
the mobilization of stored iron, however, would place additional stress on the cell because
assembly of [2Fe-2S] clusters in Bfd molecules would further deplete the levels of available
iron. In contrast, a structural role in which apo-Bfd participates by binding to BfrB has the
clear advantage of enabling utilization of stored iron without taxing the very resources that
may allow cell survival under adverse conditions.
Binding of Bfd to BfrB enables heme mediation of electron transfer
It is noteworthy that reduction of the heme in P. aeruginosa BfrB occurs only in the presence
of P. aeruginosa Bfd, which suggests that formation of a BfrB-Bfd complex enables the heme
in the bacterioferritin to mediate electrons from the reductase to the core. Mediation of electron
transfer is clearly manifested when limiting concentrations of NADPH (Figure 9) cause a
transient buildup of reduced heme. Although heme mediation of electron transfer has
previously been speculated (42) the function of heme in bacterioferritins has been difficult to
establish. Findings from the present investigation make it apparent that the function of the heme
in core iron mobilization can only be properly examined by reconstituting BfrB with Bfd
because binding of the two physiological partner proteins is a prerequisite for making the heme
“conductive”. The specific mechanism whereby heme is made “conductive” upon binding of
Bfd is not understood at the moment, although some possible scenarios follow: (a) Formation
of a complex with Bfd positively shifts the reduction potential of the heme in BfrB and enables
it to accept electrons from FPR, (b) binding of Bfd causes conformational changes in BfrB that
enable an electron transfer path from the surface to the heme; that is, acceleration of the electron
transfer rate without a change in the driving force for the reaction, (c) the conformational
changes brought about by binding Bfd both, alter the heme redox potential and enable a path
for electron conduction and (d) binding of Bfd to Bfr may facilitate productive binding of the
reductase, thus accelerating electron transfer to BfrB that is channeled to the core via the heme.
Although additional work aimed at unraveling these possibilities is necessary to gather
mechanistic information regarding the process of iron mobilization from bacterioferritin, it is
clear that future studies directed at probing the mechanism of iron mobilization from
bacterioferritins have to be conducted in the presence of the appropriate physiological partner
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protein. In this context, it is noteworthy that a recent study demonstrated that Bfd is necessary
to recycle iron from Bfr in Erwinia chrysanthemi cells (43).
The rate of iron release from mammalian ferritins is thought to be controlled by “pore-gates”
that open and close pores used for transporting Fe2+ ions from the core to the surface; “pore
gates” are thought to regulate the outflow of Fe2+ by melting/ordering local structure (24).
Given that very low concentrations of urea can melt the “pore gates”, it has been suggested
that physiological regulators recognize them and protect the stored iron from leaking simply
by exposure to physiological reductants in the cell (41). Peptides selected from a combinatorial
library were also shown to unfold pores in the structure of mammalian ferritin and accelerate
the mobilization of core iron (44). The presence of similar “pore gates” has not yet been
demonstrated in bacterioferritins, although structural investigations suggest the presence of
pores for the intake and release of iron into and out of the core (7,8,26,27). Structural work
with Azotobacter vinelandii Bfr, which exhibits the closest amino acid sequence homology to
P. aeruginosa BfrB (Figure 1), showed redox-dependent conformational changes of several
important residues in or near the ferroxidase center and the observation of iron at the four-fold
pores (27). These observations, which are consistent with the idea that iron may enter (and
perhaps leave) ferritin via these pores (7), support the notion of gated traffic of iron into and
out of the bacterioferritin core. Hence, it is tempting to hypothesize that binding of Bfd to BfrB
causes structural rearrangements that not only enable the heme to mediate electron transfer to
the core mineral, but also open pore gates that enable the outflow of Fe2+. The amino acid
sequence of Bfd does not hold any relationship to the sequence of the combinatorial peptides
known to accelerate iron mobilization from mammalian ferritins. Thus, it is clear that additional
investigations aimed at structurally characterizing BfrB and the Bfd-BfrB complex are
necessary to dissect the effect exerted by Bfd on the structure of BfrB.
Bfd is likely not a classic ferredoxin
Early work with E. coli Bfd showed that the recombinant protein can be isolated from E.
coli host cells with an intact [2Fe-2S] cluster analogous to that contained by bacterial and plant
ferredoxins (9,10). These observations together with the conservation of four Cys residues in
the sequence of several Bfd genes, led to its classification as a ferredoxin, and the position of
the bfd gene, upstream of the bfrB gene, resulted in the name bacterioferritin associated
ferredoxin. Observations made during the present investigations show that apo-Bfd is fully
functional in the mobilization of stored iron, demonstrating that assembly of an iron sulfur
cluster is not necessary, at least for the purpose of mobilizing iron from BfrB. These findings
strongly suggest that Bfd does not function in the classical electron transfer role of ferredoxins.
In fact, inspection of the amino acid sequence alignment in Figure 2 shows that the four
conserved cysteine residues thought to act as ligands for the iron in the [2Fe-2S] cluster are
organized in a C-X-C-X31–32-C-X2-C arrangement. This unique arrangement and a relatively
short peptide, which is approximately 50 residues shorter than typical [2Fe-2S] ferredoxins of
bacteria, plants, fungi and vertebrates, lend support to the notion that Bfds do not function in
the classical electron transfer role of ferredoxins. The resonance Raman spectral features of
oxidized Bfd are nearly identical to those of the [2Fe-2S] cluster in the second domain of NifU
(9,11), a multi-domain protein required for the assembly of the metallocluster in nitrogenase
(45). This has led to the suggestion that Bfds may function as a scaffold for the assembly of
[2Fe-2S] clusters for subsequent assembly into other proteins and enzymes that utilize iron
sulfur clusters (9–11). Assembly of a transient [2Fe-2S] cluster in Bfds is consistent with the
fragility of this center and is not in disagreement with the role played by apo-Bfd in the
mobilization of iron stored in BfrB, because it is possible that iron released from BfrB is
coordinated by the four conserved Cys residues in Bfd to form a mononuclear iron center. Iron
coordinated in this manner can be transported and delivered to where is needed, or alternatively,
with the aid of proteins involved in the iron sulfur cluster assembly machinery (Isc), be used
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to form a transient [2Fe-2S] cluster in Bfd that can be transferred to a nascent ferredoxin. The
ability to accommodate a tetracoordinated mononuclear iron center that can be converted into
a [2Fe-2S] cluster may be built, at least partially, in the C-X-C motif, because its amino terminal
position (see Figure 2) likely facilitates the conformational freedom that allow the
corresponding Cys ligands to adapt to a mononuclear or dinuclear iron center. Clearly
additional investigations with Bfd are needed to shed light on this issue.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
REFERENCES
1. Andrews SC, Robinson AK, Rodríguez-Quiñones F. Bacterial Iron Homeostasis. FEMS Microbiology
Reviews 2003;27:215–237. [PubMed: 12829269]
2. Smith L. The Physiological Role of Ferritin-Like Compounds in Bacteria. Crit. Rev. Microbiol
2004;30:173–185. [PubMed: 15490969]
3. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM. Ferritin and the Response to Oxidative
Stress. Biochem J 2001;357:241–247. [PubMed: 11415455]
4. Moore GR, Kadir HA, Al-Massad K, Le Brun NE, Thomson AJ, Greenwood C, Keen JN, Findlay
JBC. Structural Heterogeneity of Pseudomonas aeruginosa Bacterioferritin. Biochem J
1994;304:493–497. [PubMed: 7998985]
5. Ma J-F, Ochsner UA, Klotz MG, Nanayakkara VK, Howell ML, Johnson Z, Posey JE, Vasil ML,
Monaco JJ, Hassett DJ. Bacterioferritin A Modulates Catalase A (KatA) Activity and Resistance to
Hydrogen Peroxide in Pseudomonas aeruginosa. J. Bacteriol 1999;181:3730–3742. [PubMed:
10368148]
6. Frolow F, Kalb AJ, Yariv J. Structure of a Unique Twofold Symmetric Haem-Binding Site. Nat. Struct.
Biol 1994;1
7. Liu H-L, Zhou H-N, Xing W-M, Zhao J-F, Li S-X, Huang J-F, Bi R-C. 2.6 Å Resolution Crystal
Structure of the Bacterioferritin from Azotobacter vinelandii. FEBS Lett 2004;573:93–98. [PubMed:
15327981]
8. Janowski R, Auerbach-Nevo T, Weiss MS. Bacterioferritin from Mycobacterium smegmatis Contains
Zinc in its Di-Nuclear Site. Prot. Sci 2007;17:1138–1150.
9. Quail MA, Jordan P, Grogan JM, Butt JN, Lutz M, Thomson AJ, Andrews SC, Guest JR. Spectroscopic
and Voltammetric Characterization of Bacterioferritin-Associated Ferredoxin of Escherichia coli.
Biochem. Biophys. Res. Commun 1996;229:635–642. [PubMed: 8954950]
10. Garg RP, Vargo CJ, Cui X, Kurtz DMJ. A [2Fe-2S] Protein Encoded by an Open Reading Frame
Upstream of the Escherichia coli Bacterioferritin Gene. Biochemistry 1996;35:6297–6301.
[PubMed: 8639572]
11. Wang A, Zeng Y, Han H, Weeratunga S, Morgan BN, Moënne-Loccoz P, Schönbrunn E, Rivera M.
Biochemical and Structural Characterization of Pseudomonas aeruginosa Bfd and FPR: Ferredoxin
NADP+ Reductase and Not Ferredoxin is the Redox Partner of Heme Oxygenase under Iron-
Starvation Conditions. Biochemistry 2007;46:12198–12211. [PubMed: 17915950]
12. Palma M, Worgall S, Quadri LEN. Transcriptome Analysis of the Pseudomonas aeruginosa Response
to Iron. Arch. Microbiol 2003;180:374–379. [PubMed: 14513207]
13. Vasil ML, Ochsner UA. The Response of Pseudomonas aeruginosa to Iron: Genetics, Biochemistry
and Virulence. Mol. Microbiol 1999;34:399–413. [PubMed: 10564483]
14. Wilderman PJ, Sowa NA, FitzGerald DJ, FitGerald PC, Gottesman S, Ochsner UA, Vasil ML.
Identification of Tandem Duplicate Regulatory Small RNAs in Pseudomonas aeruginosa Involved
in Iron Homeostasis. Proc. Natl. Acad. Sci. USA 2004;101:9792–9797. [PubMed: 15210934]
15. Ochsner UA, Wilderman PJ, Vasil AI, Vasil ML. GeneChip Expression Analysis of the Iron Starvation
Response in Pseudomonas Aeruginosa: Identification of Novel Pyoverdine Biosynthesis Genes. Mol.
Microbiol 2002;45:1277–1287. [PubMed: 12207696]
Weeratunga et al. Page 13













16. Pereira AS, Small W, Krebs C, Tavares P, Edmondson DE, Theil EC, Huynh BH. Direct Spectroscopic
and Kinetic Evidence for the Involvement of Peroxodiferric Intermediate during the Ferroxidase
Reaction in Fast Ferritin Mineralization. Biochemistry 1998;37:9871–9876. [PubMed: 9665690]
17. Le Brun NE, Wilson MT, Andrews SC, Guest JR, Harrison PM, Thomson AJ, Moore GR. Kinetic
and Structural Characterization of an Intermediate in the Biomineralization of Bacterioferritin. FEBS
Lett 1993;333:197–202. [PubMed: 8224163]
18. Carrondo MA. Ferritins, Iron Uptake and Storage from the Bacterioferritin Viewpoint. EMBO J
2003;22:1959–1968. [PubMed: 12727864]
19. Andrews SC. Iron Storage in Bacteria. Advan. Microbial Physiol 1998;40:281–351.
20. Mann S, Williams JM, Treffry A, Harrison PM. Reconstituted and Native Iron-Cores of
Bacterioferritin and Ferritin. J. Mol. Biol 1987;198:405–416. [PubMed: 3123700]
21. Topham R, Goger M, Pearce K, Schultz P. The Mobilization of Ferritin Iron by Liver Cytosol.
Biochem J 1989;261:137–143. [PubMed: 2775199]
22. Takagi H, Shi D, Ha Y, Allewell NM, Theil EC. Localized Unfolding at the Junction of Three Ferritin
Subunits. J. Biol. Chem 1998;27318685-18618-18688
23. Liu X, Jin W, Theil EC. Opening Protein Pores with Chaotropes Enhances Fe Reduction and Chelation
of Fe from the Ferritin Biomineral. Proc. Natl. Acad. Sci. USA 2003;100:3653–3658. [PubMed:
12634425]
24. Jin W, Takagi H, Pancorbo B, Theil EC. "Opening" the Ferritin Pore for Iron Release by Mutation
of Conserved Amino Acids at Interhelix and Loop Sites. Biochemistry 2001;40:7525–7532.
[PubMed: 11412106]
25. Liu X, Theil EC. Ferritins: Dynamic Management of Biological Iron and Oxygen Chemistry. Acc.
Chem. Res 2005;38:167–175. [PubMed: 15766235]
26. Macedo S, Romão CV, Mitchell E, Matias PM, Liu MY, Xavier AV, LeGall J, Teixeira M, Lindley
P, Carrondo MA. The Nature of the Di-Iron Site in the Bacterioferritin from Desulfovibrio
desulfuricans. Nat. Struct. Biol 2003;10:285–290. [PubMed: 12627224]
27. Swartz L, Kuchinskas M, Li H, Poulos TL, Lanzilotta WN. Redox-Dependent Structural Changes in
the Azotobacter vinelandii Bacterioferritin: New Insights into the Ferroxidase and Iron Transport
Mechanism. Biochemistry 2006;45:4421–4428. [PubMed: 16584178]
28. van Eerde A, Wolterink-van Loo S, van der Oost J, Dijkstra BW. Fortituous Structure Determination
of "As-Isolated" Escherichia coli Bacterioferritin in a Novel Crystal Form. Acta. Cryst. F
2006;62:1061–1066.
29. Andrews SC, Le Brun NE, Barynin V, Thomson AJ, Moore GR, Guest JR, Harrison PM. Site-Directed
Replacement of the Coaxial Heme Ligands of Bacterioferritin Generates Heme-free Variants. J Biol
Chem 1995;270:23268–23274. [PubMed: 7559480]
30. Ikemura T. Codon Usage and tRNA Content in Unicellular and Multicellular Organisms. Mol. Biol.
Evol 1985;2:13–34. [PubMed: 3916708]
31. Yariv J, Kalb AJ, Sperling R, Bauminger ER, S.G. C, Ofer S. The Composition and Structure of
Bacterioferritin of Escherichia coli. Biochem J 1981;197:171–175. [PubMed: 7032515]
32. Ringeling PL, Davy SL, Monkara FA, Hunt C, Dickson DPE, McEwan AG, Moore GR.
Characterization of Bacterioferritin and Formation of Non-Haem Iron Particles in Intact Cells. Eur.
J. Biochem 1994;223:847–855. [PubMed: 8055962]
33. Wang A, Rodríguez JC, Han H, Schönbrunn E, Rivera M. X-Ray Crystallographic and Solution State
Nuclear Magnetic Resonance Spectroscopic Investigations of NADP+ Binding to Ferredoxin NADP
Reductase from Pseudomonas aeruginosa. Biochemistry 2008;47:8080–8093. [PubMed: 18605699]
34. Cheesman MR, Le Brun NE, Kadir FH, Thomson AJ, Moore GR, Andrews SC, Guest JR, Harrison
PM, Smith JA, Yewdall SJ. Haem and Non-Haem Iron Sites in Escherichia coli Bacterioferritin:
Spectroscopic and Model Building Studies. Biochem J 1993;292:47–56. [PubMed: 8389131]
35. Rivera M, Walker FA. Biosynthetic Preparation of Isotopically Labeled Heme. Anal. Biochem
1995;230:295–302. [PubMed: 7503421]
36. Rivera M, Caignan GA. Recent Developments in the 13C NMR Spectroscopic Analysis of
Paramagnetic Hemes and Hemoproteins. Anal. Bioanal. Chem 2004;378:1464–1483. [PubMed:
15214408]
Weeratunga et al. Page 14













37. Watt GD, Frankel RB, Jacobs D, Huang H. Fe2+ and Phosphate Interactions in Bacterial Ferritin from
Azotobacter vinelandii. Biochemistry 1992;31:5672–5679. [PubMed: 1610815]
38. Watt GD, Frankel RB, Papaefthymiou GC, Spartalian K, Stiefel EI. Redox Properties and Mössbauer
Spectroscopy of Azotobacter vinelandii Bacterioferritin. Biochemistry 1986;1986:4330–4336.
39. Aitken-Rogers H, Singleton C, Lewin a, Taylor-Gee A, Moore GR, Le Brun NE. Effect of Phosphate
on Bacterioferritin-Catalysed Iron(II) Oxidation. J. Biol. Inorg. Chem 2004;9:161–170. [PubMed:
14673713]
40. Jones T, Spencer R, Walsh C. Mechanism and Kinetics of Iron Release from Ferritin by
Dihydroflavins and Dihydroflavin Analogues. Biochemistry 1978;17:4011–4017. [PubMed:
708692]
41. Theil EC, Liu XS, Tosha T. Gated Pores in the Ferritin Protein Nanocage. Inorg. Chim. Acta
2008;361:868–874.
42. Richards TD, Pitts KR, Watt GD. A Kinetic Study of Iron Release from Azotobacter Vinelandii
Bacterial Ferritin. J. Inorg. Biochem 1996;61:1–13. [PubMed: 8558133]
43. Expert D, Boughammoura A, Franza T. Sidreophore-Controlled Iron Assimilation in the
Enterobacterium Erwinia chrysanthemi. J. Biol. Chem 2008;283:36564–36572. [PubMed:
18990691]
44. Liu XS, Patterson LD, Miller MJ, Theil EC. Peptides Selected for the Protein Nanocage Pores Change
the Rate of Iron Recovery from the Ferritin Mineral. J. Biol. Chem 2007;282:31821–31825.
[PubMed: 17785467]
45. Dos Santos PC, Smith AD, Frazzon J, Cash VL, Johnson MK, Dean DR. Iron-Sulfur Cluster
Assembly: NifU-Directed Activation of the Nitrogenase Fe Protein. J. Biol. Chem 2004;279:19705–
19711. [PubMed: 14993221]
46. Larkin MA, Blackshields G, Brown NP, McGettigan PR, McWilliam H, Valentin F, Wallace IM,
Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. Clustal W and Clustal X Version 2.0.
Bioinformatics 2007;23:2947–2948. [PubMed: 17846036]
Weeratunga et al. Page 15













Figure 1. Bacterioferritin sequences from different organisms aligned against P. aeruginosa BfrB
(P.a. BfrB)
Residues involved in the ferroxidase center, as well as Met-52, which coordinates the heme
axially, are highlighted. Note that Met52 is absent in the sequence of P. aeruginosa BfrA. The
sequences were aligned with the aid of ClustalW (46).
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Figure 2. Bacterioferritin-associated ferredoxin sequences from different organisms aligned
against that from P. aeruginosa Bfd
Conserved cysteines forming the unique C-X-C-X31–32-CX2-C arrangement (highlighted) are
thought to bind iron in the [2Fe-2S] cluster of the holo-protein. The sequences were aligned
with the aid of ClustalW (46).
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Figure 3. Characterization of recombinant BfrB
(A) 15 % SDS-PAGE analysis of BfrB purified to homogeneity. (B) Electronic absorption
spectra of oxidized-heme (full line) and reduced-heme (dashed line) BfrB in 100 mM potassium
phosphate, pH 7.6. The inset shows the corresponding bands in the visible region. Note the
750 nm band in the oxidized-heme spectrum, which is characteristic of bis-methionine ligation.
(C) Spectral changes observed upon reconstituting recombinant BfrB with exogenous heme.
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Figure 4. Reconstitution of core iron mineral in recombinant BfrB
The family of electronic absorption spectra illustrates the intensity changes brought about by
reconstituting the core of BrfB with iron. Note the large increase in the intensity of the band
near 280 nm as the iron mineral grows in the core of the bacterioferritin. The small change in
the intensity of the Soret absorbance is due to small loses of protein due to the formation of
small amounts of colloidal hydrous oxide (see text). The spectrum with a dotted line was
acquired before the addition of ferrous ammonium sulfate, and the spectrum with the full line,
after the addition of the equivalent to 650 iron atoms per BfrB molecule.
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Figure 5. Bfd accelerates the mobilization of core iron from BfrB
(A) Time dependent increase in the intensity of the 523 nm absorbance due to the formation
of Fe[(bipy)3]2+ upon addition of NADPH (1.5 mM final concentration) to a solution
containing BfrB (0.375 µM), FPR (15 µM), bipy (3 mM) and (●) no Bfd, (○) 15 µM wild type
holo-Bfd, and (▲) wild type apo-Bfd. (B) Before the arrow: time dependent absorption changes
in the intensity of the 523 nm caused by sequestration of the iron in the [2Fe-2S] cluster of (●)
15 µM wild type holo-Bfd and (○) 15 µM holo-C43S Bfd by bipy (3 mM); the solution
contained 15 µM sodium dithionite to reduce the two iron ions in holo-Bfd. After the arrow:
the resultant solution containing 15 µM apo-Bfd (●) or apo-C43S-Bfd (○) was made 0.375 µM
in BfrB and 15 µM in FPR, before addition of NADPH (1.5 mM) started the rapid time
dependent increase in the 523 nm absorption.
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Figure 6. Effect of Bfd concentration on the time-dependent processes of iron mobilization and
heme reduction
(A) Time dependent plot of absorption intensity change measured at 523 nm upon addition of
NADPH (1.5 mM ) to solutions containing 3.0 mM bipy, 15 µM FPR, 0.375 µM BfrB and
apo-Bfd with Bfd/Bfrb molar ratio of 40 (green), 30 (red), 20 (purple), 15 (cyan), 10 (blue), 5
(orange) and 0 (black). (B) Time dependent changes in the position of the Soret band brought
about by the addition of NADPH (1.5 mM) to the solutions in figure A; 417.5 nm and 425 nm
correspond to fully oxidized and fully reduced heme, respectively. (C) Zoomed view (initial
11 min) of the time dependent absorption changes corresponding to the plots in A. (D) Zoomed
view of the time dependent changes in the position of the Soret band corresponding to the plots
in B.
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The release of core iron from BfrB is Bfd-dependent.
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Figure 8. Bfd binds to BfrB
(A) The calibration curve obtained to estimate the molecular weight of BfrB (○) and that of
the BfrB-Bfd complex (Δ) was constructed from the elution volume (Ve) obtained for each of
the following standard molecular weight markers: (●), ferritin (440 kDa), aldolase (158 kDa),
conalbumin (75 kDa), and ovalbumin (44 kDa), loaded onto a Superdex 200 column. The
average Ve (two measurements) obtained for pure BfrB (58.9 ± 0.05 mL) corresponds to a MW
of 447 ± 1 kDa. (B) Two peaks were obtained upon loading the Superdex 200 column with a
mixture of Bfd:BfrB in a mole ratio of 24: The peak with Ve = 57.0 ± 0.6 mL (MW ~ 538 kDa
±) contains a mixture of BfrB and Bfd (lane 2), whereas the peak with Ve = 96.3 mL contains
only Bfd (lane 1). The presence of both Bfd and BfrB in peak with Ve = 57.0 mL indicates the
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formation of a stable complex between Bfd and BfrB and the difference in average Ve obtained
from loading pure BfrB and a Bfrb:Bfd mixture is ~ 91 kDa, suggesting that ~ 12 molecules
of Bfd bind a BfrB molecule.
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Figure 9. Binding of Bfd to BfrB promotes heme mediation of electron transfer to the core iron
Open circles, left axis: time dependent changes in the intensity of absorption measured at 523
nm upon addition of aliquots of NADPH containing 15% of the total electron equivalents
needed to reduce all the ferric ions in the core of BfrB (600 Fe3+ ions/BfB) to a solution
containing BfrB (0.375 µM), Fpr (15 µM), apo-Bfd (15 µM ) bipy (3 mM). Dark circles, right
axis: time dependent changes in the position of the heme Soret band following addition of each
NADPH aliquot. The measurements were conducted at 22 °C.
Weeratunga et al. Page 25

























Weeratunga et al. Page 26
Table 1
Pseudo rates for the Bfd-dependent release of core iron mineral from BfrB.
Bfd / BfrB
molar ratio
Pseudo rate of iron
release (min−1)a,b
0 0.0087 ± 0.0002
5 0.029 ± 0.001
10 0.036 ± 0.002
15 0.058 ± 0.008
20 0.074 ± 0.008
30 0.089 ± 0.007
40 0.095 ± 0.004
a
The standard deviations were obtained from triplicate measurements using proteins obtained from two independent preparations.
b
Measurements were carried out at 25 °C
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